Evidence map›Paper›PMID 40775734›Full record

ArticleGenome medicine2025

Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicine.

Hanna M Hieromnimon, James Dolezal, Kristina Doytcheva, Frederick M Howard, Sara Kochanny, Zhenyu Zhang, Robert L Grossman, Kevin Tanager, Cindy Wang, Jakob Nikolas Kather and 5 more

Abstract read
In one paragraph

Article in Genome medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hanna M HieromnimonGraduate Program in Biophysical Sciences, University of Chicago, Chicago, IL, USA.
James DolezalDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Kristina DoytchevaDepartment of Pathology, University of Chicago, Chicago, IL, USA.
Frederick M HowardDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Sara KochannyDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Zhenyu ZhangCenter for Translational Data Science, University of Chicago, Chicago, IL, USA.
Robert L GrossmanCenter for Translational Data Science, University of Chicago, Chicago, IL, USA.
Kevin TanagerDepartment of Pathology, University of Chicago, Chicago, IL, USA.
Cindy WangDepartment of Pathology, University of Chicago, Chicago, IL, USA.
Jakob Nikolas KatherElse Kroener Fresenius Center for Digital Health, University Hospital Carl Gustav Carus Dresden, Technical University Dresden, Dresden, Germany.
Evgeny IzumchenkoDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Nicole A CiprianiDepartment of Pathology, University of Chicago, Chicago, IL, USA.
Elana J FertigDepartments of Oncology, Biomedical Engineering, and Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, MD, USA.
Alexander T PearsonDepartment of Medicine, University of Chicago, Chicago, IL, USA. alexander.pearson@bsd.uchicago.edu.
Samantha J RiesenfeldDepartment of Medicine, University of Chicago, Chicago, IL, USA. sriesenfeld@uchicago.edu.

Funding

Graduate Program in Biophysical Sciences at the University of Chicago - Renewal 0T32EB009412 · NIBIB · UNIVERSITY OF CHICAGO · PI ENGEL, GREGORY S, SOSNICK, TOBIN R · 2009 to 2023
$4.9M
National Institute of Biomedical Imaging and Bioengineering T32 training grant 5 T32 EB 9412-13NIBIB NIH HHS T32 EB009412
6 · The paper itself

Abstract

backgroundPrecision oncology depends on identifying the biological vulnerabilities of a tumor. Molecular assays, like transcriptomics, provide an information-rich view of the tumor that can be leveraged to inform therapeutic selection. However, the costs of such assays can be prohibitive for clinical translation at scale. Histology-based imaging remains a predominant means of diagnosis that is widely accessible. To more broadly leverage limited molecular datasets, models have been trained to use histology to infer the expression of individual genes or pathways, with varying levels of accuracy and explainability.

methodsOur approach detects expression of transcriptional programs from tumor histology and interprets the image features supporting program detection. Specifically, we used RNA-seq data from squamous cell carcinoma (SCC) patients to infer cohesive expression patterns of multiple genes. Then, we used deep learning techniques to train a computational model to predict the activity levels of the transcriptional programs directly from histology images. We exploited that predictive capability to generate synthetic digital models of the cellular histology of each transcriptional program, using generative adversarial networks to isolate image features supporting specific transcriptional predictions and pathologist review to interpret the images.

resultsApplying our histologically integrated latent space analysis to SCCs revealed sets of genes associated with both pathologist-interpretable image features and clinically relevant processes, including immune response, collagen remodeling, and fibrosis, going beyond predictions of individual molecular features.

conclusionsOur results demonstrate an approach for discovering clinically interpretable histological features that indicate molecular, potentially treatment-informing, biological processes. These features are detectable in widely available histology slides, allowing a standard microscope to deliver complex, patient-specific molecular information.

Indexed as

Deep LearningImage Processing, Computer-AssistedNeoplasmsPrecision MedicineTranscriptomeBiomarkers, TumorCarcinoma, Squamous CellComputer SimulationGenerative Adversarial NetworksHumansRNA-SeqBiomarkers, TumorComputational pathologyDeep learningGene expressionMultimodal learningPrecision oncologySquamous cell carcinomasSynthetic histology

Identifiers

PMID40775734
PMCPMC12329968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.